ASTRAZENECA PLC AZN
ORD · Common Stock · CUSIP G0593M107
British-Swedish pharmaceutical company
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersCambridge, Sweden
- Founded1913
- Websiteastrazeneca.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $162.98.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 3 |
| Q4 2022 | 4 |
| Q1 2023 | 5 |
| Q2 2023 | 4 |
| Q3 2023 | 2 |
| Q4 2023 | 3 |
| Q1 2024 | 4 |
| Q2 2024 | 4 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 1 | 2 |
| Q1 2023 | 1 | 1 |
| Q2 2023 | 1 | 1 |
| Q3 2023 | 1 | 2 |
| Q4 2023 | 1 | 1 |
| Q1 2024 | 1 | 2 |
| Q2 2024 | 2 | 1 |
Biggest buyers
| KENNEDY CAPITAL MANAGEMENT LLC | Added | +26.7k |
| FNY Investment Advisers, LLC | New | +200 |
Biggest sellers
| Boston Common Asset Management, LLC | Reduced | -10.9k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| BlackRock, Inc. 13G · institution filed 2025-04-23 | 7.6% |
| VANGUARD CAPITAL MANAGEMENT LLC 13G · institution new · filed 2026-04-28 | 5.0% |
Insider purchases and sales in Q2 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2024.
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| Boston Common Asset Management, LLC 1.16% of their portfolio | 288.8k $45.1m | Reduced -10.9k |
| KENNEDY CAPITAL MANAGEMENT LLC 0.21% of their portfolio | 64.2k $10.0m | Added +26.7k |
| RAFFA WEALTH MANAGEMENT, LLC 0.01% of their portfolio | 464 $36.2k | Unchanged |
| FNY Investment Advisers, LLC 1.67% of their portfolio | 200 $2.5m | New |